Disruptor Profile: Day Zero Diagnostics, Inc.
- Pages: 10
- Published: July 2019
- Report Code: GDDT0278DC
Day Zero Diagnostics Inc. is a medical technology company, which is developing a new class of diagnostics, including whole genome sequencing-based diagnostics, for modernizing the diagnosis and treatment of infectious disease using genome sequencing and machine learning (ML) technologies.
The report provides information and insights into Day Zero Diagnostics, Inc.'s, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on funding
– Biography of top management
Reasons to buy
– Gain insights into Day Zero Diagnostics Inc.’s business operations.
– Gain insights into fundings
– Gain understanding about its technology focus.
Sands Capital Ventures LLC
Golden Seeds LLC
National Institute of Allergies
Infectious Disease (NIAID)
Table of Contents
Table of contents